A poly(I:C)/QS-21-based in situ vaccine synergizes with anti-PD-1 therapy to overcome tumor immunoresistance. (linkinghub.elsevier.com)

Authors: Zhang W … Li X Journal: Cell Reports Medicine Published: 2026-07-22 DOI: https://doi.org/10.1016/j.xcrm.2026.102932